Abstract
: Hematological toxicity following Chimeric Antigen Receptor-T therapy in a patient with a prior allogeneic stem cell transplantation was resolved by the infusion of unselected donor-derived stem cell boost. Due to the donor's lymphocytes, the patient experienced a well-controlled flare-up of acute graft versus host disease.
| Original language | English |
|---|---|
| Pages (from-to) | N/A-N/A |
| Journal | American Journal of Hematology |
| Issue number | Jan |
| DOIs | |
| Publication status | Published - 2024 |
All Science Journal Classification (ASJC) codes
- Hematology
Keywords
- N/A
Fingerprint
Dive into the research topics of 'Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver